Pathstone Holdings, LLC

Position in HLN — Haleon plc

CIK 2011612 ENGLEWOOD, NJ

Position in HLN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,559,036

+$293,205 QoQ

Shares Held

155,748

+24.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 84.82035082312453.ToString("F0")% Shared 0.31396871869943754.ToString("F0")% None 14.865680458176028.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $39,823,834 across 16 Drug Manufacturers - Specialty & Generic names. HLN ranks #8 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	305,467	$7,309,824
2	ZTS	Zoetis Inc.	57,358	$6,780,288
3	TEVA	Teva Pharmaceutical Industries Ltd	164,003	$4,939,769
4	TAK	Takeda Pharmaceutical Co Ltd	241,293	$4,468,745
5	ALKS	Alkermes plc.	81,988	$2,899,094
6	UTHR	UNITED THERAPEUTICS Corp	4,828	$2,862,906
7	NBIX	Neurocrine Biosciences Inc	11,857	$1,562,041
8	HLN	Haleon plc This page	155,748	$1,559,036

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,559,036	155,748	+24.4%	Shares	Other	2026-05-11
2025-12-31	$1,265,831	125,206	+4.5%	Shares	Defined	2026-02-13
2025-09-30	$1,074,685	119,809	-6.1%	Shares	Sole	2025-11-13
2025-06-30	$1,322,837	127,564	-1.1%	Shares	Sole	2025-08-12
2025-03-31	$1,326,904	128,951	-5.4%	Shares	Sole	2025-05-15
2024-12-31	$1,300,883	136,361	+1.5%	Shares	Sole	2025-02-14
2024-09-30	$1,421,094	134,319	-0.4%	Shares	Sole	2024-11-07
2024-06-30	$1,113,917	134,857	+12.9%	Shares	Sole	2024-08-14
2024-03-31	$1,013,968	119,431	-11.4%	Shares	Sole	2024-05-13
2023-12-31	$1,109,246	134,781	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.